The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index; 24 of the 34 sources its claims cite were checked for support.
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Open accessAbstract
The evolutionary conserved Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) complex is one of the crucial multiprotein complexes that facilitates endosomal recycling of transmembrane proteins. Defects in WASH components have been associated with inherited developmental and neurological disorders in humans. Here, we show that hepatic ablation of the WASH component Washc1 in chow-fed mice increases plasma concentrations of cholesterol in both LDLs and HDLs, without affecting hepatic cholesterol content, hepatic cholesterol synthesis, biliary cholesterol excretion, or hepatic bile acid metabolism. Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1. Hepatic WASH ablation also reduced the surface levels of scavenger receptor class B type I and, concomitantly, selective uptake of HDL cholesterol into the liver. Furthermore, we found that WASHC1 deficiency increases LDLR proteolysis by the inducible degrader of LDLR, but does not affect proprotein convertase subtilisin/kexin type 9–mediated LDLR degradation. Remarkably, however, loss of hepatic WASHC1 may sensitize LRP1 for proprotein convertase subtilisin/kexin type 9–induced degradation. Altogether, these findings identify the WASH complex as a regulator of LDL as well as HDL metabolism and provide in vivo evidence for endosomal trafficking of scavenger receptor class B type I in hepatocytes.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Hepatic ablation of Washc1 in mice destabilizes the WASH complex, alters lysosomal architecture, and raises plasma LDL-C and HDL-C by reducing hepatocyte surface LDLR/LRP1 and SR-BI, respectively. WASH deficiency also accelerates IDOL-mediated LDLR degradation and may sensitize LRP1 to PCSK9-induced degradation.
Key findings
- In chow-fed Washc1 ΔHep mice, total plasma cholesterol increased without changes in triglycerides; LDL and HDL fractions were cholesterol-enriched, ApoB and ApoE were increased, and HDL particles were larger. With adenoviral human CETP expression, Washc1 ΔHep mice still had higher total cholesterol, LDL-C, HDL-C, ApoB, ApoA-I, and ApoE than WT mice.
- Hepatic WASH loss reduced hepatocyte surface levels of LDLR and LRP1. PCSK9-D377Y expression exacerbated hypercholesterolemia in Washc1 ΔHep mice and increased ApoB48/ApoB100; LRP1 levels decreased upon PCSK9 overexpression only in WASH-deficient livers.
- SR-BI surface levels were decreased in WASH-deficient primary hepatocytes, and selective hepatic HDL-CE uptake was reduced, while HDL holoparticle clearance was unchanged.
- WASH deficiency accelerated IDOL-mediated LDLR degradation but did not affect PCSK9-mediated LDLR degradation in MEFs. Hepatic Washc1/Commd1 double knockout did not further increase total plasma cholesterol compared with single knockouts. Lysosomal tubulation was 14.8% (37/250) in Washc1-ablated hepatocytes versus 4.4% (11/250) in WT.
Methods
- Liver-specific Washc1-knockout mice were generated by crossing Washc1 fl/fl mice with Alb-Cre mice; mice were 12–20 weeks old, predominantly male, chow-fed, and fasted 4 hours before sacrifice (n = 4–7). Additional models included liver-specific Commd1 knockout, AAV-PCSK9-D377Y, and Ad-CETP.
- Analyses included primary hepatocyte biotinylation for surface LDLR, LRP1, and SR-BI; MEFs for PCSK9- and IDOL-mediated LDLR degradation; transmission EM; FPLC; targeted proteomics; radioactive HDL turnover; qRT-PCR; and hepatic lipid, biliary, and fecal sterol/bile acid measurements.
- Statistics used unpaired two-tailed Student’s t test with P < 0.05; in vitro data were from 3 independent experiments.
Limitations
- The paper does not include a dedicated limitations section. It states that the mechanism by which PCSK9 lowers hepatic LRP1 in Washc1 ΔHep mice is unclear and that future experiments are needed, and it suggests that more significant conditions may be required to unmask a biliary cholesterol phenotype.
- Evident from the text: findings are from mouse models, predominantly male, chow-fed, with adenoviral/AAV perturbations; no human validation is presented, and the LRP1 sensitization conclusion is speculative.
- Evident from the text: in vitro LDLR degradation experiments use MEFs rather than hepatocytes, and the Washc1/Commd1 double-knockout characterization focuses on plasma lipids rather than all proposed mechanisms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
24 of 34 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Individuals heterozygous for a loss-of-function variant in SCARB1 (P376L) have increased levels of plasma HDL-C.
“Individuals who are heterozygous for a loss-of-function variant in SCARB1 (P376L), the gene encoding SR-BI, have increased levels of plasma HDL-C (56).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] source
- Premisecitation
Loss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1.
“we have shown that loss of the CCC complex leads to increased expression of several WASH subunits, including WASHC1 (17).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [17] source
In “Stability of COMMD Proteins Associated With the CCC Complex Depends on Other COMMD Proteins” (page unavailable), the paper reports that loss of COMMD1 or COMMD6 reduced CCC core subunits and increased expression of the WASH component WASH1, also called WASHC1. It does not report increased expression of several WASH subunits; its mention of FAM21 concerns colocalization, not increased expression. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Interpretationown data
The itinerary of PCSK9-LDLR to the lysosome is spatially separated from the LDLR recycling route.
“These data indicate that the itinerary of PCSK9-LDLR to the lysosome is spatially separated from the LDLR recycling route (11,23,63).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [11] source
The section “Retrieval and degradative functions of the endosome are spatially segregated” says that degradative and retrieval complexes occupy distinct endosomal subdomains, though it describes cargo segregation as a possibility. “The CCC complex” identifies LDLR as recycling cargo. The paper does not establish that PCSK9-bound LDLR specifically follows a spatially separate itinerary to the lysosome. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [23] source
The Abstract distinguishes endosomal recycling from lysosomal degradation, and the Results mention machinery involved in LDLR recycling, but neither addresses the itinerary of PCSK9-bound LDLR or its spatial relationship to the LDLR recycling route. Searches for PCSK9 and spatial separation found no passage making that comparison; no page numbers are available in our copy. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [63] source
The ‘Cargo fate decisions at the endosome’ section (p. 4) describes recycling cargo being retrieved into tubular carriers rather than entering the degradative pathway, and the reference annotation (p. 35) identifies LDLR as a recycling cargo. The copy does not establish that PCSK9-bound LDLR follows a spatially separate itinerary to the lysosome. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Both LDL-C and HDL-C are elevated in patients with X-linked intellectual disability caused by mutations in CCDC22.
“both LDL-C and HDL-C are elevated in patients with X-linked intellectual disability caused by mutations in the gene encoding the CCC-complex component CCDC22 (16).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source
The Results section, “CCDC22 mutations are associated with hypercholesterolaemia” (page unavailable), reports elevated LDL cholesterol in patients with CCDC22-related X-linked intellectual disability. It reports elevated total cholesterol, but does not establish that HDL cholesterol is elevated in those patients. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
A patient with RSS with a homozygous hypomorphic WASHC5 allele has relatively high plasma HDL-C levels.
“plasma HDL-C levels were also reported to be relatively high in a patient with RSS with a homozygous hypomorphic WASHC5 allele (16).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source
The Results section (‘COMMD1 and WASH facilitate LDLR trafficking’; page unavailable) reports one RSS patient with a homozygous KIAA0196 mutation that reduced strumpellin levels, and gives the patient’s HDL-C as 1.5 mmol/L. It describes total and LDL cholesterol—not HDL-C—as elevated, so the characterization of HDL-C as ‘relatively high’ is not established by the paper. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Findingcitation
Ectopic expression of CETP decreases total cholesterol levels in mice.
“In agreement with previous studies (33,34), ectopic expression of CETP decreased TC levels in mice (Figure 3B)”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [33] source
- cites [34] source
The Discussion describes SR-BI trafficking and biliary cholesterol secretion, not CETP expression or total cholesterol levels in mice. Searches for CETP ectopic expression and total cholesterol in mice found no passage addressing the attributed finding. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Interpretationown data
The diminished surface levels of SR-BI accompanied by reduced selective hepatic HDL-CE uptake suggest that the functioning of SR-BI is dependent on the WASH complex.
“The diminished surface levels of SR-BI accompanied by reduced selective hepatic HDL-CE uptake suggest that the functioning of SR-BI-the main receptor for hepatic HDL-C uptake in mice (54, 55)-is dependent on the WASH complex.”
Quote in the paperSubstantial claim2 of 2 sources checked - Premisecitation
PCSK9 does not have an effect on hepatic LRP1 degradation in WT mice.
“although PCSK9 does not have an effect on hepatic LRP1 degradation in WT mice (17,37,38)”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [17] source
In the hepatic CCC-complex ablation results (page unavailable), PCSK9-D377Y reduced hepatic LDLR protein expression but not LRP1 protein expression in WT mice. This supports no observed effect on LRP1 abundance under that condition, but the paper does not directly measure LRP1 degradation or establish the claim for PCSK9 generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [37] source
The Results section (‘PCSK9-mediated LDLR Degradation in the Liver Does Not Require LRP1’) reports that PCSK9 infusion did not affect hepatic LRP1 levels in WT mice, and the Discussion reiterates this finding. The paper reports protein levels, not a direct measurement of LRP1 degradation, so the claim is more specific than the evidence. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [38] source
The Discussion reports that hepatic LRP protein levels were not significantly different in wild-type mice parabiosed with PCSK9-overexpressing mice. This supports a lack of detectable effect on LRP abundance, but the passage does not establish that PCSK9 has no effect on LRP1 degradation specifically. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
The CCC complex is physically associated with the WASH complex through binding of CCDC93 and CCDC22 to WASHC2.
“the CCC complex is physically associated with the WASH complex through the binding of the CCC components CCDC93 and CCDC22 to the WASH subunit WASHC2 (FAM21) (5).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [5] source
- Findingown data
Hepatic ablation of Washc1 does not affect hepatic bile acid metabolism.
“However, these changes did not translate into aberrant biliary cholesterol and bile acid excretion nor in altered fecal neutral sterol and bile acid loss (Supplemental Figure 3, E-H).”
Quote in the paperNot a substantial claim - Findingown data
Hepatic ablation of Washc1 does not affect hepatic cholesterol synthesis.
“We found that hepatic Washc1 ablation did not affect hepatic cholesterol and TG contents, VLDL production, and whole-body cholesterol synthesis rates (Supplemental Figure 3, A-D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of Washc1 does not affect hepatic cholesterol content.
“We found that hepatic Washc1 ablation did not affect hepatic cholesterol and TG contents, VLDL production, and whole-body cholesterol synthesis rates (Supplemental Figure 3, A-D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of Washc1 does not affect biliary cholesterol excretion.
“However, these changes did not translate into aberrant biliary cholesterol and bile acid excretion nor in altered fecal neutral sterol and bile acid loss (Supplemental Figure 3, E-H).”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of Washc1 in chow-fed mice increases plasma LDL cholesterol.
“the cholesterol content of the LDL fraction separated by fast protein liquid chromatography (FPLC) was increased (Figure 2, C and D).”
Quote in the paperSubstantial claim - Findingown data
Plasma HL levels are not different between Washc1 ΔHep and WT mice.
“we did not find any difference in plasma HL levels as measured by targeted proteomics (Figure 5B)”
Quote in the paperSubstantial claim - Findingown data
Impaired endosomal LDLR recycling by loss of WASHC1 does not affect PCSK9-mediated LDLR degradation.
“Here, we demonstrate that impaired endosomal LDLR recycling by the loss of WASHC1 does not affect PCSK9-mediated LDLR degradation.”
Quote in the paperSubstantial claim - Findingown data
Hepatic Washc1 depletion exacerbates hypercholesterolemia in PCSK9-induced hepatic LDLR deficiency.
“We found that hepatic Washc1 depletion exacerbated hypercholesterolemia in PCSK9-induced hepatic LDLR deficiency (Figure 4F).”
Quote in the paperSubstantial claim - Findingown data
Total protein levels of LRP1 are reduced in WASH-deficient primary hepatocytes.
“In addition to the surface levels, the total protein levels of LDLR and LRP1 were also reduced in WASH-deficient primary hepatocytes (Figure 4, A and B).”
Quote in the paperSubstantial claim - Findingown data
Hepatic expression of PCSK9 increases ApoA-I levels in the WASH/LDLR-deficient model.
“Hepatic expression of PCSK9 also increased ApoA-I levels in this model, while HDL-C levels were unchanged (Figure 4H).”
Quote in the paperNot a substantial claim - Findingown data
CETP expression normalizes the increased HDL particles in Washc1 ΔHep mice.
“CETP expression normalized the increased HDL particles in the Washc1 ΔHep mice (Figure 2C) compared with Washc1 ΔHep mice without CETP expression (Figure 3C)”
Quote in the paperNot a substantial claim - Findingown data
Plasma ApoB48 and ApoB100 levels are elevated in mice deficient for hepatic WASH and LDLR compared with mice lacking only hepatic LDLR.
“plasma ApoB48 and ApoB100 levels were elevated in mice deficient for hepatic WASH and LDLR compared with mice lacking only hepatic LDLR (Figure 4, H and I).”
Quote in the paperSubstantial claim - Findingown data
In Washc1 ΔHep mice with CETP expression, ApoA-I levels are increased compared with WT mice.
“However, in Washc1 ΔHep , the LDL-C, HDL-C, as well as the apolipoproteins ApoB, Apo-AI, and ApoE levels were increased compared with WT mice (Figure 3, C and D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic inactivation of the WASH complex does not affect plasma triglyceride levels.
“Hepatic inactivation of the WASH complex increased TC without affecting TG levels (Figure 2A).”
Quote in the paperNot a substantial claim - Findingown data
WASHC1 deficiency accelerates LDLR proteolysis promoted by IDOL.
“However, WASHC1 deficiency does accelerate LDLR proteolysis promoted by IDOL.”
Quote in the paperSubstantial claim - Findingown data
Washc1 ΔHep mice show an increase in HDL-C.
“Interestingly, however, we also found an increase in HDL-C in Washc1 ΔHep mice.”
Quote in the paperSubstantial claim - Findingown data
WASHC1 deficiency increases LDLR proteolysis by IDOL.
“loss of WASHC1 accelerated IDOL-mediated LDLR degradation.”
Quote in the paperSubstantial claim - Findingown data
In Washc1 ΔHep mice with CETP expression, ApoE levels are increased compared with WT mice.
“However, in Washc1 ΔHep , the LDL-C, HDL-C, as well as the apolipoproteins ApoB, Apo-AI, and ApoE levels were increased compared with WT mice (Figure 3, C and D).”
Quote in the paperNot a substantial claim - Findingown data
PCSK9 decreases total LDLR levels in WT and WASHC1-deficient cells.
“Immunoblots showed that PCSK9 decreased total LDLR levels in WT and WASHC1-deficient cells”
Quote in the paperSubstantial claim - Findingown data
Hepatic WASHC1 deficiency reduces the abundance of all WASH components.
“hepatic WASHC1 deficiency strongly reduced the abundance of all WASH components (Figure 1, A and B)”
Quote in the paperSubstantial claim - Findingown data
Washc1 ΔHep mice have increased plasma ApoB levels.
“we observed increased plasma levels of apolipoproteins ApoE and ApoB in Washc1 ΔHep mice compared with WT mice (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
Loss of WASHC1 accelerates IDOL-mediated LDLR degradation.
“loss of WASHC1 accelerated IDOL-mediated LDLR degradation.”
Quote in the paperSubstantial claim - Findingown data
No significant differences in the mRNA levels of SREBP-2 target genes Ldlr and Hmgcr were found in Washc1 ΔHep mice.
“No significant differences in the mRNA levels of the SREBP-2 target genes, such as Ldlr and Hmgcr, were found (Supplemental Table 1).”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of both WASH and CCC complexes does not further increase total plasma cholesterol levels compared with single knockouts.
“Hepatic ablation of both complexes did not further increase total plasma cholesterol levels when compared with hepatic Washc1 and Commd1 single-knockout mice (Figure 6B).”
Quote in the paperSubstantial claim - Findingown data
Loss of hepatic WASH does not noticeably alter the morphology of Golgi, endoplasmic reticulum, or mitochondria.
“However, the loss of hepatic WASH did not noticeably alter the morphology of other organelles such as Golgi, endoplasmic reticulum, or mitochondria.”
Quote in the paperNot a substantial claim - Findingown data
Holoparticle uptake is not changed in hepatic WASH-deficient mice.
“whereas holoparticle uptake was not changed (Figure 5D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic expression of human CETP shifts cholesterol from HDL toward LDL in both Washc1 ΔHep and WT mice.
“Hepatic expression of human CETP resulted in the expected shift of cholesterol from HDL toward LDL in both Washc1 ΔHep and WT mice (Figure 3C).”
Quote in the paperNot a substantial claim - Findingown data
Loss of WASHC1 does not affect the degradation kinetics of LDLR by PCSK9.
“but loss of WASHC1 did not affect the degradation kinetics of LDLR by PCSK9 (Figure 7, B and C).”
Quote in the paperSubstantial claim - Findingown data
Washc1 ΔHep mice have increased plasma ApoE levels.
“we observed increased plasma levels of apolipoproteins ApoE and ApoB in Washc1 ΔHep mice compared with WT mice (Figure 2B).”
Quote in the paperSubstantial claim - Findingown data
Several LXR target genes, including Abcg5, Abcg8, and Cyp7a1, are decreased upon hepatic Washc1 depletion.
“Several liver X receptor (LXR) targets, including genes involved in biliary cholesterol secretion and bile acid synthesis (Abcg5, Abcg8, and Cyp7a1) were decreased upon hepatic Washc1 depletion compared to WT livers (Supplemental Table 1)”
Quote in the paperNot a substantial claim - Findingown data
Hepatic WASH ablation reduces surface levels of SR-BI in hepatocytes.
“We found the cell surface abundance of SR-BI to be markedly decreased in WASH-deficient hepatocytes compared with WT cells (Figure 5A).”
Quote in the paperSubstantial claim - Findingown data
Selective HDL-CE uptake by Washc1 ΔHep livers is significantly decreased compared with WT livers.
“the difference reflecting selective HDL-CE uptake by Washc1 ΔHep livers was significantly decreased compared with WT livers (Figure 5E).”
Quote in the paperSubstantial claim - Findingown data
Hepatic inactivation of the WASH complex increases total plasma cholesterol.
“Hepatic inactivation of the WASH complex increased TC without affecting TG levels (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
Hepatic ablation of the WASH complex decreases the average size of lysosomes.
“Hepatic ablation of the WASH complex decreased the average size of the lysosomes (Figure 1, C and D).”
Quote in the paperSubstantial claim - Findingown data
In the absence of the WASH complex, LRP1 levels are significantly decreased upon PCSK9 overexpression in mouse livers.
“we found that in the absence of the WASH complex, LRP1 levels were significantly decreased upon PCSK9 overexpression in mouse livers (Figure 4, C and D, and Supplemental Figure 4).”
Quote in the paperSubstantial claim - Findingown data
3H-HDL-CE clearance is delayed upon hepatic WASH inactivation.
“However, 3 H-HDL-CE clearance was delayed upon hepatic WASH inactivation (Figure 5C).”
Quote in the paperSubstantial claim - Findingown data
Overexpression of PCSK9 lowers hepatic LRP1 levels in Washc1 ΔHep mice.
“Our data also unexpectedly suggest that overexpression of PCSK9 lowers hepatic LRP1 levels in Washc1 ΔHep mice.”
Quote in the paperNot a substantial claim - Findingown data
Hepatic WASH ablation reduces selective uptake of HDL cholesterol into the liver.
“the difference reflecting selective HDL-CE uptake by Washc1 ΔHep livers was significantly decreased compared with WT livers (Figure 5E).”
Quote in the paperSubstantial claim - Findingown data
In Washc1 ΔHep mice with CETP expression, HDL-C levels are increased compared with WT mice.
“However, in Washc1 ΔHep , the LDL-C, HDL-C, as well as the apolipoproteins ApoB, Apo-AI, and ApoE levels were increased compared with WT mice (Figure 3, C and D).”
Quote in the paperSubstantial claim - Findingown data
The decrease in LRP1 levels upon PCSK9 overexpression in WASH-deficient livers is not caused by a decrease in Lrp1 mRNA levels.
“As shown in Figure 4E, this modest decrease in LRP1 levels was not caused by a decrease in Lrp1 mRNA levels.”
Quote in the paperNot a substantial claim - Findingown data
WASH is required for normal levels of LRP1 at the cell surface.
“we learned that WASH is also required for normal levels of LRP1 at the cell surface (Figure 4, A and B).”
Quote in the paperSubstantial claim - Findingown data
In CETP-expressing Washc1 ΔHep mice, total cholesterol levels are significantly higher than in WT mice.
“but the TC levels were significantly higher in CETP-expressing Washc1 ΔHep mice compared with WT mice (Figure 3B).”
Quote in the paperSubstantial claim - Findingown data
In Washc1 ΔHep mice with CETP expression, ApoB levels are increased compared with WT mice.
“However, in Washc1 ΔHep , the LDL-C, HDL-C, as well as the apolipoproteins ApoB, Apo-AI, and ApoE levels were increased compared with WT mice (Figure 3, C and D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic expression of PCSK9 does not change HDL-C levels in the WASH/LDLR-deficient model.
“Hepatic expression of PCSK9 also increased ApoA-I levels in this model, while HDL-C levels were unchanged (Figure 4H).”
Quote in the paperNot a substantial claim - Findingown data
Cell surface levels of LDLR are reduced in plasma membranes of WASH-deficient primary hepatocytes.
“We found that the levels of LDLR were reduced in the plasma membranes of WASH-deficient primary hepatocytes compared with WT cells (Figure 4, A and B).”
Quote in the paperSubstantial claim - Findingown data
WASHC1 deficiency does not affect PCSK9-mediated LDLR degradation.
“loss of WASHC1 did not affect the degradation kinetics of LDLR by PCSK9 (Figure 7, B and C).”
Quote in the paperSubstantial claim - Findingown data
PCSK9-D377Y expression blunts hepatic LDLR levels in both Washc1 ΔHep and WT mice.
“In both Washc1 ΔHep and WT mice, the expression of PCSK9-D377Y blunted hepatic LDLR levels (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
Hepatic WASHC1 deficiency does not affect the mRNA levels of WASH subunits.
“without affecting the mRNA levels of these subunits”
Quote in the paperNot a substantial claim - Findingown data
HDL-CE clearance in hepatic WASH-deficient mice is significantly reduced compared with WT mice.
“we calculated plasma fractional catabolic rates and observed that HDL-CE clearance in hepatic WASH-deficient mice was significantly reduced compared with WT mice”
Quote in the paperSubstantial claim - Findingown data
In Washc1 ΔHep mice with CETP expression, LDL-C levels are increased compared with WT mice.
“However, in Washc1 ΔHep , the LDL-C, HDL-C, as well as the apolipoproteins ApoB, Apo-AI, and ApoE levels were increased compared with WT mice (Figure 3, C and D).”
Quote in the paperSubstantial claim - Findingown data
Hepatic Washc1 ablation does not affect VLDL production.
“We found that hepatic Washc1 ablation did not affect hepatic cholesterol and TG contents, VLDL production, and whole-body cholesterol synthesis rates (Supplemental Figure 3, A-D).”
Quote in the paperSubstantial claim - Findingown data
WASHC1 deficiency destabilizes the WASH complex in liver.
“WASHC1 deficiency destabilizes the WASH complex and perturbs lysosomal structures in primary hepatocytes.”
Quote in the paperSubstantial claim - Findingown data
Fecal neutral sterol and bile acid loss are unaffected in WASHC1-deficient mice.
“Importantly, fecal neutral sterol and bile acid loss were unaffected in WASHC1-deficient mice, indicating unaffected whole-body cholesterol turnover.”
Quote in the paperSubstantial claim - Findingown data
Plasma decay of holoparticle HDL is not different between WT and Washc1 ΔHep mice.
“Plasma decay of radioiodine reflecting holoparticle HDL was not different between WT and Washc1 ΔHep mice (Figure 5C).”
Quote in the paperSubstantial claim - Findingown data
Total protein levels of LDLR are reduced in WASH-deficient primary hepatocytes.
“In addition to the surface levels, the total protein levels of LDLR and LRP1 were also reduced in WASH-deficient primary hepatocytes (Figure 4, A and B).”
Quote in the paperSubstantial claim - Findingown data
WASH deficiency induces lysosomal tubulation in hepatocytes.
“WASH deficiency induced lysosomal tubulation (Figure 1E).”
Quote in the paperSubstantial claim - Findingown data
Hepatic WASHC1 deficiency results in increased plasma LDL-C and HDL-C in mice expressing CETP.
“Hepatic WASHC1 deficiency results in increased plasma LDL-C and HDL-C in mice expressing CETP.”
Quote in the paperSubstantial claim - Findingown data
WASH deficiency does not affect the proteolysis of LDLR by PCSK9.
“WASH deficiency increases IDOL-mediated LDLR degradation but did not affect the proteolysis of LDLR by PCSK9.”
Quote in the paperNot a substantial claim - Findingown data
Loss of hepatic WASHC1 results in increased plasma LDL-C and HDL-C.
“Loss of hepatic WASHC1 results in increased plasma LDL-C and HDL-C.”
Quote in the paperSubstantial claim - Findingown data
Hepatic uptake of HDL-C is impaired in hepatic WASH-deficient mice.
“Hepatic uptake of HDL-C is impaired by reduced surface levels of SR-BI in hepatic WASH-deficient mice.”
Quote in the paperSubstantial claim - Findingown data
WASHC1 deficiency perturbs lysosomal structures in primary hepatocytes.
“WASHC1 deficiency destabilizes the WASH complex and perturbs lysosomal structures in primary hepatocytes.”
Quote in the paperSubstantial claim - Findingown data
Cell-surface levels of SR-BI are reduced in hepatic WASH-deficient mice.
“Hepatic uptake of HDL-C is impaired by reduced surface levels of SR-BI in hepatic WASH-deficient mice.”
Quote in the paperSubstantial claim - Findingown data
WASH deficiency increases IDOL-mediated LDLR degradation.
“WASH deficiency increases IDOL-mediated LDLR degradation but did not affect the proteolysis of LDLR by PCSK9.”
Quote in the paperSubstantial claim - Interpretationown data
The hepatic WASH complex does not have a prominent role in the control of whole-body cholesterol turnover.
“These data indicate that the WASH complex in the liver plays an important role in the regulation of plasma LDL-C and HDL-C levels, but does not have a prominent role in the control of whole-body cholesterol turnover.”
Quote in the paperSubstantial claim - Interpretationown data
Elevated plasma LDL cholesterol in Washc1 ΔHep mice is related to reduced hepatocytic surface levels of LDLR.
“Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1.”
Quote in the paperSubstantial claim - Premisecitation
WASH mediates endosomal recycling of LDLR back to the cell surface in MEFs.
“We have recently shown that WASH mediates endosomal recycling of LDLR back to the cell surface in MEFs (16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source
- Interpretationown data
Elevated plasma LDL cholesterol in Washc1 ΔHep mice is related to reduced hepatocytic surface levels of LRP1.
“Elevated plasma LDL cholesterol was related to reduced hepatocytic surface levels of the LDL receptor (LDLR) and the LDLR-related protein LRP1.”
Quote in the paperSubstantial claim - Interpretationown data
HDL particles in Washc1 ΔHep mice are larger than in WT mice.
“Altogether, the shift of ApoA-I, ApoE, and HDL-C into earlier eluted FPLC fractions indicates that HDL particles in Washc1 ΔHep mice are larger than in WT mice (27)(28)(29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites (27)(28)(29)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
The WASH complex participates in the sorting of ubiquitylated LDLR by IDOL to the lysosome.
“Altogether, these data imply that the WASH complex participates in the sorting of ubiquitylated LDLR by IDOL to the lysosome.”
Quote in the paperSubstantial claim - Interpretationown data
WASH orchestrates the trafficking of LDLR, LRP1, and SR-BI to the plasma membrane for hepatic clearance of LDL-C and HDL-C.
“Our data indicate that WASH orchestrates the trafficking of the lipoprotein receptors LDLR and LRP1 as well as SR-BI to the plasma membrane for hepatic clearance of LDL-C and HDL-C, respectively.”
Quote in the paperSubstantial claim - Interpretationown data
The WASH complex is a regulator of LDL as well as HDL metabolism.
“these findings identify the WASH complex as a regulator of LDL as well as HDL metabolism”
Quote in the paperSubstantial claim - Interpretationown data
In vivo data support the notion that the WASH and CCC complexes act together to form a crucial sorting pathway required to maintain normal plasma cholesterol levels.
“These in vivo data support the notion that the WASH and CCC complexes act together to form a crucial sorting pathway that is required to maintain normal plasma cholesterol levels.”
Quote in the paperSubstantial claim - Interpretationown data
This study extends the mechanistic basis for the increased plasma cholesterol levels in humans with defects in the WASH-CCC axis.
“this study extends the mechanistic basis for the increased plasma cholesterol levels in humans with defects in the WASH-CCC axis”
Quote in the paperSubstantial claim- Rests on an assumption: The function of the WASH complex in hepatic lipoprotein receptor trafficking is conserved between mice and humans.
- Interpretationown data
LXR activation is decreased in Washc1 ΔHep mice.
“suggesting that LXR activation was decreased in Washc1 ΔHep mice.”
Quote in the paperNot a substantial claim - Interpretationown data
The disturbed endolysosomal architecture in Washc1 ΔHep mice does not cause defective intracellular cholesterol transport.
“Here, we found that the disturbed endolysosomal architecture in Washc1 ΔHep mice does not cause a defective intracellular cholesterol transport”
Quote in the paperSubstantial claim - Interpretationcitation
Hepatic WASH/LDLR deficiency mimics the plasma lipid phenotype in hepatic LRP1-deficient mice in an Ldlr-knockout background.
“Hepatic WASH/LDLR deficiency mimics the plasma lipid phenotype in hepatic LRP1-deficient mice in an Ldlr-knockout background (35)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] source
- Interpretationown data
Loss of hepatic WASHC1 may sensitize LRP1 for PCSK9-induced degradation.
“Remarkably, however, loss of hepatic WASHC1 may sensitize LRP1 for proprotein convertase subtilisin/kexin type 9-induced degradation.”
Quote in the paperSubstantial claim - Interpretationcitation
Current and previous mouse models mimic the dyslipidemic phenotype of patients with RSS and X-linked intellectual disability.
“Our current and previous mouse models mimic the dyslipidemic phenotype of patients with RSS and those with X-linked intellectual disability”
Quote in the paperSubstantial claim - Interpretationown data
The WASH and CCC complexes act in concert in the endosomal cargo recycling pathway.
“Here, we provide genetic evidence that the WASH and CCC complexes act in concert in the endosomal cargo recycling pathway”
Quote in the paperSubstantial claim - Interpretationreasoning
The WASH complex is required for hepatic LRP1-mediated cholesterol uptake in vivo.
“suggesting that the WASH complex is also required for hepatic LRP1-mediated cholesterol uptake in vivo.”
Quote in the paperSubstantial claim - Interpretationown data
It is unlikely that hepatic lipase contributes to the increased plasma HDL-C levels in hepatic WASH-deficient mice.
“which makes it unlikely that HL contributes to the increased plasma HDL-C levels in hepatic WASH-deficient mice.”
Quote in the paperSubstantial claim - Interpretationown data
The WASH complex has a pivotal role in the maintenance of plasma cholesterol levels.
“Here, we report that the WASH complex also has a pivotal role in the maintenance of plasma cholesterol levels.”
Quote in the paperSubstantial claim - Interpretationown data
The WASH complex provides in vivo evidence for endosomal trafficking of SR-BI in hepatocytes.
“provide in vivo evidence for endosomal trafficking of scavenger receptor class B type I in hepatocytes.”
Quote in the paperSubstantial claim - Interpretationown data
The WASH and CCC complexes act in concert to regulate plasma lipid levels.
“Results from previous and current studies imply that the WASH and CCC complex act in concert to regulate plasma lipid levels.”
Quote in the paperSubstantial claim - Interpretationown data
The WASH complex is essential for the architecture of the endolysosomal system in hepatocytes.
“we show that the WASH complex is also essential for the architecture of the endolysosomal system in hepatocytes”
Quote in the paperSubstantial claim - Interpretationown data
The localization of SR-BI at the plasma membrane largely relies on the WASH-CCC axis.
“Our results indicate that the localization of SR-BI at the plasma membrane largely relies on the WASH-CCC axis.”
Quote in the paperSubstantial claim - Interpretationown data
The impaired hepatic HDL-C uptake in hepatic WASH-deficient mice is caused by reduced surface levels of SR-BI.
“Hepatic uptake of HDL-C is impaired by reduced surface levels of SR-BI in hepatic WASH-deficient mice.”
Quote in the paperSubstantial claim
- Probably not a substantial claim. 13
- It may state two separate claims as one. 15
- The quote only partly states this claim. 1
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationCommon genetic variants near SCARB1 are correlated with plasma HDL-C levels.
“common genetic variants near SCARB1 have been found to be correlated with plasma HDL-C levels (57, 58)”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [57] source
The Abstract (page not provided) reports associations between serum lipid traits and SNPs near SCARB1, and New Biological, Clinical, and Genetic Insights (page not provided) identifies SCARB1 as a receptor for HDL-C. The passages do not specifically state that the variants near SCARB1 were associated with HDL-C levels, rather than another lipid trait. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [58] source
Probably not a substantial claim. The paper’s conclusions may not depend on it.
PremisecitationHepatic lipase increases hepatic HDL-CE uptake.
“It has been shown that the enzyme hepatic lipase (HL) increases hepatic HDL-CE uptake (40-43).”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [40] Amar, 1998, Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice, J Lipid Res source
The passage indexed as Abstract (page unavailable) suggests that lipolysis may be required for HL-mediated enhanced selective uptake of HDL cholesteryl esters in apoE-deficient mice. It does not establish increased hepatic HDL-CE uptake: the measured increase in liver uptake was from VLDL cholesteryl ester, not HDL. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [41] source
- cites [42] source
- cites [43] source
The Discussion says hepatic lipase enhances selective uptake of HDL-derived cholesteryl esters, citing previous studies. It does not specify that this uptake occurs in the liver; its discussion of a possible mechanism also considers delivery to adrenal cells. The hepatic location in the citing claim is therefore not established by our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured
It may state two separate claims as one.
PremisecitationA role for PCSK9 in hepatic LRP1 degradation in WT mice or in hepatic COMMD1-deficient mice could not be confirmed.
“However, we and others could not confirm a role for PCSK9 in hepatic LRP1 degradation in WT mice, nor in hepatic COMMD1-deficient mice (17,37,38).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [17] source
- cites [37] source
Checked before — its earlier verdict is held back until a new check runs.
- cites [38] source
The Discussion reports that hepatic LRP protein levels were not significantly different in wild-type mice exposed to circulating PCSK9, supporting the WT-mouse part of the claim. The paper does not address hepatic COMMD1-deficient mice, so it cannot support that part. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
PremisecitationPCSK9 can bind to and decrease LRP1 in different cell lines.
“It has been shown that PCSK9 can bind to and decrease LRP1 in different cell lines (64).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [64] source
The Results section, “PCSK9 enhances the degradation of LRP-1 in HEK293 and HepG2 cells” (page unavailable), reports decreased LRP-1 levels in multiple cell lines. The Discussion considers PCSK9–LRP-1 binding affinity, but the passages found do not establish direct binding, so that part of the claim is not fully supported. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim. It may state two separate claims as one.
PremisecitationSR-BI is endocytosed and localized in recycling endosomes.
“Several studies have shown that SR-BI is endocytosed (59,60) and localized in recycling endosomes (60).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [59] source
The section on holo-HDL particle uptake reports internalization of SR-BI-GFP alongside HDL, supporting SR-BI endocytosis. The passage on the endosomal recycling compartment describes HDL particles being transported there, not localization of SR-BI itself; the copy does not establish that part of the claim. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [60] source
It may state two separate claims as one.
InterpretationcitationHepatocyte-specific WASH deficiency leads to reduced LDLR and LRP1 levels in the plasma membrane, which likely underlies elevated plasma LDL-C levels in Washc1 ΔHep mice.
“In agreement with our in vitro studies (16), hepatocyte-specific WASH deficiency leads to reduced LDLR and LRP1 levels in the plasma membrane, which likely underlies elevated plasma LDL-C levels in Washc1 ΔHep mice.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [16] Bartuzi, 2016, CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL, Nat Commun source
The Results section, “COMMD1 and WASH facilitate LDLR trafficking” (page unavailable), reports reduced cell-surface LDLR and LDL uptake in WASH1-deficient mouse embryonic fibroblasts, supporting the reference to in vitro studies. It does not establish reduced plasma-membrane LRP1 or elevated LDL-C in hepatocyte-specific WASH-deficient mice; its hepatic knockout results concern Commd1 instead. (LLM, conf=0.88)
Experimental — accuracy not yet measured
The quote only partly states this claim.
Findingown dataHepatic ablation of Washc1 in chow-fed mice increases plasma HDL cholesterol.
“We also found the HDL fraction to be enriched with cholesterol and increased in size (Figure 2C).”
Quote in the paperSubstantial claimIt may state two separate claims as one.
FindingreasoningImpairment of the WASH-CCC axis only leads to reduced HDL-CE uptake without affecting ApoA-I clearance or its plasma levels.
“an impairment of the WASH-CCC axis only led to reduced HDL-CE uptake without affecting ApoA-I clearance as well as its plasma levels”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Findingown dataHepatic ablation of both WASH and CCC complexes results in increased plasma LDL-C and larger HDL-C particles similar to single knockouts.
“In addition, hepatic ablation of both complexes also resulted in increased plasma LDL-C (Figure 6, C and D) and larger HDL-C particles (Figure 6, C and D), similar to that was seen in single-knockout models”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Findingown dataHepatic LXR activity is slightly reduced upon Washc1 ablation.
“Although hepatic LXR activity was slightly reduced upon Washc1 ablation”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataRenal uptake rate of HDL-CE is much lower than hepatic HDL-CE uptake, and no differences are observed between WT and Washc1 ΔHep mice.
“the renal uptake rate of HDL-CE was much lower than with hepatic HDL-CE uptake, and no differences were observed between WT and Washc1 ΔHep mice (data not shown).”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataTargeted proteomics shows a leftward shift of ApoA-I and ApoE in Washc1/Commd1 ΔHep mice, confirming that HDL particles are larger.
“targeted proteomics analysis of FPLC fractions showed a leftward shift of ApoA-I and ApoE (Figure 6E), confirming that the HDL particles are also larger in Washc1/Commd1 ΔHep mice”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Findingown dataFemale Washc1 ΔHep mice also show increased total cholesterol, LDL-C, and larger HDL particles.
“An increase in TC, LDL-C, and larger HDL particles was also seen in female Washc1 ΔHep mice (Supplemental Figure 2, A-C).”
Quote in the paperNot a substantial claimProbably not a substantial claim.
Interpretationown dataThis work provides insights into the role of the WASH complex in IDOL- and PCSK9-mediated LDLR degradation.
“our work provides insights in the role of the WASH complex in IDOL-and PCSK9-mediated LDLR degradation.”
Quote in the paperSubstantial claimIt may state two separate claims as one.
Interpretationown dataHepatic WASHC1 deficiency does not result in dysfunctional lysosomes and aberrant intracellular cholesterol transport or cholesterol synthesis, despite abnormal architecture.
“Altogether, our data provide no evidence that hepatic WASHC1 deficiency results in dysfunctional lysosomes and aberrant intracellular cholesterol transport or cholesterol synthesis, despite their abnormal architecture.”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationIn mice, the role of hepatic LRP1 in the clearance of plasma cholesterol is redundant, as LDLR can compensate for LRP1 loss.
“In mice, the role of hepatic LRP1 in the clearance of plasma cholesterol is redundant, as LDLR can compensate for LRP1 loss (35).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] source
It may state two separate claims as one.
Interpretationown dataThe WASH complex participates in the IDOL-LDLR degradation pathway but not in the PCSK9-LDLR axis.
“Taken together, these results suggest that the WASH complex participates in the IDOL-LDLR degradation pathway but not in the PCSK9-LDLR axis.”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationIn mice, HDL-C is mainly cleared by SR-BI, which selectively takes up CE from HDL rather than internalizing the holoparticle.
“In mice, HDL-C is mainly cleared by SR-BI, a membrane receptor that selectively takes up CE from HDL rather than internalizing the holoparticle (39).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] source
It may state two separate claims as one.
InterpretationreasoningBoth the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.
“suggesting that both the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.”
Quote in the paperSubstantial claim- Rests on an assumption: The function of the WASH complex in hepatic lipoprotein receptor trafficking is conserved between mice and humans.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
Interpretationown dataNo changes in biliary cholesterol excretion were found, which may suggest that a compensatory adaptive response is induced.
“Yet, we did not find any changes in biliary cholesterol excretion, which may suggest that a compensatory adaptive response is induced.”
Quote in the paperNot a substantial claimIt may state two separate claims as one.
Interpretationown dataHepatic depletion of WASH impairs the functioning of both LDLR and LRP1 in the uptake of plasma cholesterol, leading to hypercholesterolemia.
“These data demonstrate that hepatic depletion of WASH impairs the functioning of both LDLR and LRP1 in the uptake of plasma cholesterol leading to hypercholesterolemia”
Quote in the paperSubstantial claimProbably not a substantial claim.
PremisecitationThe endolysosomal system is fundamental for the PCSK9- and IDOL-mediated degradation pathways.
“The endolysosomal system is fundamental for the PCSK9-and IDOL-mediated degradation pathways (18)(19)(20)(21)(22).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites (18)(19)(20)(21)(22)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
It may state two separate claims as one.
PremisecitationThe interaction between the CCC and WASH complexes is required for localization of the CCC complex to endosomes and for endosomal trafficking of integral membrane proteins.
“This interaction is required for the localization of the CCC complex to endosomes and subsequently for endosomal trafficking of integral membrane proteins.”
Quote in the paperSubstantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenFor EM analysis, 25 random images per block were collected for each mouse per condition, giving 100 random images per condition.
“Twenty-five random images per block were collected for each mouse per condition (100 random images per condition).”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductown dataIn vitro data were obtained from 3 independent experiments.
“In vitro data were obtained from 3 independent experiments ± SEM.”
Quote in the paperNot a substantial claimProbably not a substantial claim. The paper’s conclusions may not depend on it.
Study design and conductnone givenAll animal studies were approved by the Institutional Animal Care and Use Committee, University of Groningen (Groningen, the Netherlands).
“All animal studies were approved by the Institutional Animal Care and Use Committee, University of Groningen (Groningen, the Netherlands).”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The function of the WASH complex in hepatic lipoprotein receptor trafficking is conserved between mice and humans.
“suggesting that both the CCC and WASH complexes are required for efficient hepatic LDL-C and HDL-C uptake in men and mice.”
“this study extends the mechanistic basis for the increased plasma cholesterol levels in humans with defects in the WASH-CCC axis”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The CCC and WASH complexes act together to facilitate endosomal trafficking of LDLR.
“Previous reports found the CCC and WASH complexes act together to facilitate endosomal trafficking of LDLR.17 30 31”
From Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome (2023) · cites this paper as [31]
Loss of WASH is associated with decreased surface LDLR and increased plasma cholesterol.
“Loss of WASH is associated with decreased surface LDLR and increased plasma cholesterol98.”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Stated mouse sample-size range excludes a reported group
MinorThe Methods give a mouse sample-size range of 4-7, while the Figure 6 legend reports groups of up to 9 mice.
“Mouse data show average values ± SEM (n = 4-7).”
“(B) Total plasma cholesterol of male Washc1 ΔHep , Commd1 ΔHep , and Washc1/Commd1 ΔHep mice and their littermate controls (WT) (n = 6-9).”
Methods say all experiments used male mice despite reported female-mouse results
MinorThe Methods state that all experiments used male mice, but the Results explicitly report an experiment in female mice.
“All experiments have been performed with male mice (n = 4-7).”
“An increase in TC, LDL-C, and larger HDL particles was also seen in female Washc1 ΔHep mice (Supplemental Figure 2, A-C).”
PCSK9 dose differs by 1,000-fold
MinorThe Figure 7 legend gives a PCSK9 concentration of 2.5 mg/ml, whereas the Results and Methods give 2.5 μg/ml for the same MEF incubation.
“(B) MEFs were cultured in sterol-depleted medium for 24 hours and then incubated with recombinant human PCSK9 (2.5 mg/ml) for the indicated times.”
“WT and WASHC1-deficient MEFs (ref.16 and Figure 7A) were incubated with recombinant human PCSK9 (2.5 μg/ml), and whole-cell extracts were harvested at different time points (Figure 7B).”
CETP and non-CETP figure references are reversed
MinorThe comparison identifies Figure 2C as the CETP-expressing condition and Figure 3C as the condition without CETP, but the Figure 3 caption explicitly identifies Figure 3C as after Ad-CETP administration.
“CETP expression normalized the increased HDL particles in the Washc1 ΔHep mice (Figure 2C) compared with Washc1 ΔHep mice without CETP expression (Figure 3C)”
“(C) Cholesterol levels of FPLC fractionated pooled plasma of the experimental groups of mice after Ad-CETP administration (n = 5-6).”
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Cellular cholesterol trafficking and compartmentalization
Ikonen, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2336 · Cited by 1,506
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Hatch, F. T., & Lees, R. S. (1968) · Advances in lipid research · doi:10.1016/b978-1-4831-9942-9.50008-5 · Cited by 1,235
Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice
Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B., Anderson, N. N., Ho, Y. K., Hammer, R. E., & Horton, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29383 · Cited by 681
The Arp2/3 Activator WASH Controls the Fission of Endosomes through a Large Multiprotein Complex
Derivery, E., Sousa, C., Gautier, J. J., Lombard, B., Loew, D., & Gautreau, A. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.010 · Cited by 602
To degrade or not to degrade: Mechanisms and significance of endocytic recycling
Cullen, P. J., & Steinberg, F. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0053-7 · Cited by 590
Zanoni, P., Khetarpal, S. A., Larach, D. B., Hancock-Cerutti, W. F., Millar, J. S., Cuchel, M., DerOhannessian, S., Kontush, A., Surendran, P., Saleheen, D., et al. (2016) · Science · doi:10.1126/science.aad3517 · Cited by 545
Self-citationPCSK9: a convertase that coordinates LDL catabolism
Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800091-jlr200 · Cited by 533
A FAM21-Containing WASH Complex Regulates Retromer-Dependent Sorting
Gomez, T. S., & Billadeau, D. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.009 · Cited by 521
Self-citationGlass, C. K., Pittman, R. C., Weinstein, D. B., & Steinberg, D. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5435 · Cited by 486
Temkin, P., Lauffer, B., Jäger, S., Cimermancic, P., Krogan, N. J., & von Zastrow, M. (2011) · Nature Cell Biology · doi:10.1038/ncb2252 · Cited by 459
Rohlmann, A., Gotthardt, M., Hammer, R. E., & Herz, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1240 · Cited by 455
Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling
McNally, K. E., Faulkner, R., Steinberg, F., Gallon, M., Ghai, R., Pim, D., Langton, P., Pearson, N., Danson, C. M., Nägele, H., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3610 · Cited by 346
Self-citationGenetic Variant of the Scavenger Receptor BI in Humans
Vergeer, M., Korporaal, S. J. A., Franssen, R., Meurs, I., Out, R., Hovingh, G. K., Hoekstra, M., Sierts, J. A., Dallinga-Thie, G. M., Motazacker, M. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0907687 · Cited by 317
Self-citationInduction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
Bjørklund, M. M., Hollensen, A. K., Hagensen, M. K., Dagnæs‐Hansen, F., Christoffersen, C., Mikkelsen, J. G., & Bentzon, J. F. (2014) · Circulation Research · doi:10.1161/circresaha.114.302937 · Cited by 317
Sequence-Dependent Sorting of Recycling Proteins by Actin-Stabilized Endosomal Microdomains
Puthenveedu, M. A., Lauffer, B., Temkin, P., Vistein, R., Carlton, P., Thorn, K., Taunton, J., Weiner, O. D., Parton, R. G., & von Zastrow, M. (2010) · Cell · doi:10.1016/j.cell.2010.10.003 · Cited by 317
Zhang, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25327 · Cited by 267
Autophagy, lipophagy and lysosomal lipid storage disorders
Ward, C., Martínez-López, N., Otten, E. G., Carroll, B., Maetzel, D., Singh, R., Sarkar, S., & Korolchuk, V. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.006 · Cited by 254
Harbour, M. E., Breusegem, S. Y. A., Antrobus, R., Freeman, C., Reid, E., & Seaman, M. N. J. (2010) · Journal of Cell Science · doi:10.1242/jcs.071472 · Cited by 246
Phillips-Krawczak, C. A., Singla, A., Starokadomskyy, P., Deng, Z., Osborne, D. G., Li, H., Dick, C. J., Gomez, T. S., Koenecke, M., Zhang, J.-S., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1073 · Cited by 246
Self-citationHarbour, M. E., Breusegem, S. Y., & Seaman, M. N. J. (2012) · Biochemical Journal · doi:10.1042/bj20111761 · Cited by 238
Jia, D., Gomez, T. S., Metlagel, Z., Umetani, J., Otwinowski, Z., Rosen, M. K., & Billadeau, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913293107 · Cited by 232
Self-citationCanuel, M., Sun, X., Asselin, M.-C., Paramithiotis, E., Prat, A., & Seidah, N. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064145 · Cited by 227
Silver, D. L., Wang, N., Xiao, X., & Tall, A. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101726200 · Cited by 223
Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice
Kok, T., Hulzebos, C. V., Wolters, H., Havinga, R., Agellon, L. B., Stellaard, F., Shan, B., Schwarz, M., & Kuipers, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306309200 · Cited by 223
Self-citationCellular functions of WASP family proteins at a glance
Alekhina, O., Burstein, E., & Billadeau, D. D. (2017) · Journal of Cell Science · doi:10.1242/jcs.199570 · Cited by 220
Self-citationRetromer-mediated endosomal protein sorting: all WASHed up!
Seaman, M. N. J., Gautreau, A. M., & Billadeau, D. D. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.04.010 · Cited by 209
Self-citationWASH and the Arp2/3 complex regulate endosome shape and trafficking
Duleh, S. N., & Welch, M. D. (2010) · Cytoskeleton · doi:10.1002/cm.20437 · Cited by 207
CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
Bartuzi, P., Billadeau, D. D., Favier, R., Rong, S., Dekker, D., Fedoseienko, A., Fieten, H., Wijers, M., Levels, J. H., Huijkman, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms10961 · Cited by 205
Self-citationJia, D., Gomez, T. S., Billadeau, D. D., & Rosen, M. K. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-12-1059 · Cited by 200
Self-citationWASH inhibits autophagy through suppression of Beclin 1 ubiquitination
Xia, P., Wang, S., Du, Y., Zhao, Z., Shi, L., Sun, L., Huang, G., Ye, B., Li, C., Dai, Z., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.189 · Cited by 194
Tietge, U., Maugeais, C., Cain, W. J., Grass, D., Glick, J., de Beer, F. D., & Rader, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10077 · Cited by 190
Yamashita, S., Sprecher, D. L., Sakai, N., Matsuzawa, Y., Tarui, S., & Hui, D. Y. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114764 · Cited by 183
Mutations in the KIAA0196 Gene at the SPG8 Locus Cause Hereditary Spastic Paraplegia
Valdmanis, P. N., Meijer, I. A., Reynolds, A., Lei, A., MacLeod, P., Schlesinger, D., Zatz, M., Reid, E., Dion, P. A., Drapeau, P., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510782 · Cited by 182
Endosomal receptor trafficking: Retromer and beyond
Wang, J., Fedoseienko, A., Chen, B., Burstein, E., Jia, D., & Billadeau, D. D. (2018) · Traffic · doi:10.1111/tra.12574 · Cited by 180
Self-citationEndosomal retrieval of cargo: Retromer is not alone
McNally, K. E., & Cullen, P. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.005 · Cited by 169
Koo, C., Innerarity, T. L., & Mahley, R. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38968-8 · Cited by 162
Gomez, T. S., Gorman, J. A., Artal-Martinez de Narvajas, A., Koenig, A. O., & Billadeau, D. D. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0101 · Cited by 161
Self-citationIntracellular Cholesterol Transport by Sterol Transfer Proteins at Membrane Contact Sites
Luo, J., Jiang, L., Yang, H., & Song, B. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.10.001 · Cited by 156
Gordon, S. M., Li, H., Zhu, X., SHAH, A. S., Lu, L. J., & Davidson, W. S. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00213 · Cited by 150
Hong, C., Duit, S., Jalonen, P., Out, R., Scheer, L., Sorrentino, V., Boyadjian, R., Rodenburg, K. W., Foley, E., Korhonen, L., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123729 · Cited by 142
Guyard‐Dangremont, V., Desrumaux, C. M., Gambert, P., Lallemant, C., & Lagrost, L. (1998) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(98)10038-x · Cited by 138
Fedoseienko, A., Wijers, M., Wolters, J. C., Dekker, D., Smit, M., Huijkman, N., Kloosterhuis, N., Klug, H., Schepers, A., Willems van Dijk, K., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312004 · Cited by 126
Self-citationHuby, T., Doucet, C., Dachet, C., Ouzilleau, B., Ueda, Y., Afzal, V., Rubin, E., Chapman, M. J., & Lesnik, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26893 · Cited by 124
Pagler, T. A., Rhode, S., Neuhofer, A., Laggner, H., Strobl, W., Hinterndorfer, C., Volf, I., Pavelka, M., Eckhardt, E. R. M., van der Westhuyzen, D. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510261200 · Cited by 119
Sites and mechanisms of uptake and degradation of high density and low density lipoproteins
Pittman, R. C., & Steinberg, D. H. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34435-7 · Cited by 105
Wang, Y., Huang, Y., Hobbs, H. H., & Cohen, J. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028563 · Cited by 104
Dichek, H. L., Brecht, W., Fan, J., Ji, Z.-S., McCormick, S. P. A., Akeefe, H., Conzo, L., Sanan, D. A., Weisgraber, K. H., Young, S. G., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1896 · Cited by 101
Kuipers, F., van Ree, J. M., Hofker, M. H., Wolters, H., Veld, G. I., Havinga, R., Vonk, R. J., Princen, H. M., & Havekes, L. M. (1996) · Hepatology · doi:10.1002/hep.510240138 · Cited by 91
Self-citationNDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation
Pietiäinen, V., Vassilev, B., Blom, T., Wang, W., Nelson, J., Bittman, R., Bäck, N., Zelcer, N., & Ikonen, E. (2013) · Journal of Cell Science · doi:10.1242/jcs.128132 · Cited by 89
Scotti, E., Calamai, M., Goulbourne, C. N., Zhang, L., Hong, C., Lin, R. R., Choi, J., Pilch, P. F., Fong, L. G., Zou, P., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01716-12 · Cited by 81
Ropers, F. G., Derivery, E., Hu, H., Garshasbi, M., Karbasiyan, M., Herold, M. J., Nürnberg, G., Ullmann, R., Gautreau, A. M., Sperling, K., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr158 · Cited by 81
Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI
Nieland, T. J. F., Ehrlich, M., Krieger, M., & Kirchhausen, T. L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.02.007 · Cited by 70
Elliott, A. M., Simard, L. R., Coghlan, G., Chudley, A. E., Chodirker, B. N., Greenberg, C. R., Burch, T., Ly, V., Hatch, G. M., & Zelinski, T. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101715 · Cited by 70
Sorrentino, V., Nelson, J. K., Maspero, E., Marques, A. R. A., Scheer, L., Polo, S., & Zelcer, N. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037713 · Cited by 68
Marotti, K. R., Castle, C. K., Murray, R. W., Rehberg, E. F., Polites, H. G., & Melchior, G. W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.736 · Cited by 67
Mechanisms of cellular cholesterol compartmentalization: recent insights
Ikonen, E. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.06.002 · Cited by 64
Hulzebos, C. V., Renfurm, L. N., Bandsma, R., Verkade, H. J., Boer, T. S., Boverhof, R., TANAKA, H. L., Mierau, I., Sauer, P. J. J., Kuipers, F., et al. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31519-4 · Cited by 63
Self-citationThe uptake of high density lipoprotein cholesteryl ester in the perfused rat liver.
Quarfordt, S. H., Hanks, J., Jones, R., & Shelburne, F. A. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85830-1 · Cited by 62
Liver-Specific Commd1 Knockout Mice Are Susceptible to Hepatic Copper Accumulation
Vonk, W. I. M., Bartuzi, P., de Bie, P., Kloosterhuis, N., Wichers, C. G. K., Berger, R., Haywood, S., Klomp, L. W. J., Wijmenga, C., & van de Sluis, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029183 · Cited by 61
Self-citationKolanczyk, M., Krawitz, P., Hecht, J., Hupalowska, A., Miaczynska, M., Marschner, K., Schlack, C., Emmerich, D., Kobus, K., Kornak, U., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.109 · Cited by 54
Amar, M. J. A., Dugi, K. A., Haudenschild, C. C., Shamburek, R. D., Foger, B., Chase, M., Bensadoun, A., Hoyt, R. F., Brewer, H. B., & Santamarina-Fojo, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33323-x · Cited by 54
Dugi, K. A., Amar, M. J. A., Haudenschild, C. C., Shamburek, R. D., Bensadoun, A., Hoyt, R. F., Fruchart-Najib, J., Madj, Z., Brewer, H. B., & Santamarina-Fojo, S. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.793 · Cited by 45
Generation of analytic plasma lipoprotein profiles using two prepacked superose 6B columns
Gerdes, L. U., Gerdes, C., Klausen, I. C., & Færgeman, O. (1992) · Clinica Chimica Acta · doi:10.1016/0009-8981(92)90348-t · Cited by 44
Pure adult-onset spastic paraplegia caused by a novel mutation in the KIAA0196 (SPG8) gene
Bot, S. T., Vermeer, S., Buijsman, W., Heister, A., Voorendt, M., Verrips, A., Scheffer, H., Kremer, H. P. H., Warrenburg, B. P. C., & Kamsteeg, E.-J. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6870-x · Cited by 39
SR-BI Undergoes Cholesterol-stimulated Transcytosis to the Bile Canaliculus in Polarized WIF-B Cells
Harder, C. J., Meng, A., Rippstein, P., McBride, H. M., & McPherson, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604627200 · Cited by 31
Fu, T., Guan, Y., Xu, J., & Wang, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.05.002 · Cited by 25
FoxO transcription factors are required for hepatic HDL cholesterol clearance
Lee, S. X., Heine, M., Schlein, C., Ramakrishnan, R., Liu, J., Belnavis, G., Haimi, I., Fischer, A. W., Ginsberg, H. N., Heeren, J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94230 · Cited by 22
Renfurm, L. N., Bandsma, R., Verkade, H. J., Hulzebos, C. V., van Dijk, T. H., Boer, T. S., Stellaard, F., Kuipers, F., & Sauer, P. J. J. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000139482.88468.46 · Cited by 18
Self-citationBrundert, M., Heeren, J., Greten, H., & Rinninger, F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300058-jlr200 · Cited by 17
Kolanczyk, M., Krawitz, P., Hecht, J., Hupalowska, A., Miaczynska, M., Marschner, K., Schlack, C., Emmerich, D., Kobus, K., Kornak, U., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.278 · Cited by 17
Abstract 554: FoxO Transcription Factors are Required for Hepatic HDL-Cholesterol Clearance
Lee, S. X. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvb.38.suppl_1.554
Flagged first, then by citations
Cited by
Sorted by citations
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
Li, H., Yu, X.-H., Ou, X., Ouyang, X.-P., & Tang, C. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101109 · Cited by 237
Heida, A., Gruben, N., Catrysse, L., Koehorst, M., Koster, M., Kloosterhuis, N. J., Gerding, A., Havinga, R., Bloks, V. W., Bongiovanni, L., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101349 · Cited by 78
Self-citationIslam, M. M., Hlushchenko, I., & Pfisterer, S. G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.826379 · Cited by 61
WASP family proteins: Molecular mechanisms and implications in human disease
Kramer, D. A., Piper, H. K., & Chen, B. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151244 · Cited by 57
Endosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
PCSK9 Promotes LDLR Degradation by Preventing SNX17-Mediated LDLR Recycling
Guan, Y., Liu, X., Yang, Z., Zhu, X., Liu, M., Du, M., Pan, X., & Wang, Y. (2025) · Circulation · doi:10.1161/circulationaha.124.072336 · Cited by 50
Taking One Step Back in Familial Hypercholesterolemia
Loaiza, N., Hartgers, M. L., Reeskamp, L. F., Balder, J.-W., Rimbert, A., Bazioti, V., Wolters, J. C., Winkelmeijer, M., Jansen, H., Dallinga‐Thie, G. M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313470 · Cited by 44
Self-citationRegulation of murine copper homeostasis by members of the COMMD protein family
Singla, A., Chen, Q., Suzuki, K., Song, J., Fedoseienko, A., Wijers, M., Lopez, A. M., Billadeau, D. D., van de Sluis, B., & Burstein, E. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045963 · Cited by 40
Self-citationVos, D. Y., & van de Sluis, B. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101146 · Cited by 35
Self-citationPathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., de Aguiar Vallim, T. Q., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 33
Ginsenosides retard atherogenesis via remodelling host–microbiome metabolic homeostasis
Wang, Y., Wu, J., Hong, Y., Zhu, J., Zhang, Y., Zhang, J., Ding, C., Che, Y., Wang, G., Jiang, A., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16320 · Cited by 29
Velagapudi, S., Rohrer, L., Potì, F., Feuerborn, R., Perisa, D., Wang, D., Panteloglou, G., Potapenko, A., Yalçınkaya, M., Hülsmeier, A. J., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316725 · Cited by 29
Rimbert, A., Dalila, N., Wolters, J. C., Huijkman, N., Smit, M., Kloosterhuis, N., Riemsma, M., van der Veen, Y., Singla, A., van Dijk, F., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz727 · Cited by 24
Self-citationZhou, J., Duan, M., Jiao, Q., Chen, C., Xing, A., Su, P., Juan, T., Zhang, H., & Liu, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.778296 · Cited by 22
Clinical diversity and molecular mechanism of VPS35L-associated Ritscher-Schinzel syndrome
Otsuji, S., Nishio, Y., Tsujita, M., Rio, M., Huber, C., Antón-Plágaro, C., Mizuno, S., Kawano, Y., Miyatake, S., Simon, M., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108602 · Cited by 19
Vos, D. Y., Wijers, M., Smit, M., Huijkman, N., Kloosterhuis, N. J., Wolters, J. C., Tissink, J. J., Pronk, A. C. M., Kooijman, S., Rensen, P. C. N., et al. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.122.318169 · Cited by 16
Self-citationA novel role for GalNAc-T2 dependent glycosylation in energy homeostasis
Verzijl, C. R. C., Oldoni, F., Loaiza, N., Wolters, J. C., Rimbert, A., Tian, E., Yang, W., Struik, D., Smit, M., Kloosterhuis, N., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101472 · Cited by 14
Self-citationZhou, G., Zhang, J., Liu, S., Dong, S., Cong, Y., Jiang, X., & Yu, W. (2024) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2024.103883 · Cited by 13
Shrestha, P., Yazdani, S., Vivès, R. R., Masri, R. E., Dam, W., van de Sluis, B., & van den Born, J. (2021) · Kidney International · doi:10.1016/j.kint.2021.01.023 · Cited by 13
Shrestha, P., Adepu, S., Vivès, R. R., Masri, R. E., Klooster, A., Kaptein, F. H. J., Dam, W., Bakker, S. J. L., van Goor, H., van de Sluis, B., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020091376 · Cited by 12
Finelli, C. (2023) · Gastrointestinal Disorders · doi:10.3390/gidisord5020020 · Cited by 12
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems
Kiss, I., Neuwert, N., Oberle, R., Hengstschläger, M., Osmanagic-Myers, S., & Stangl, H. (2025) · Biomolecules · doi:10.3390/biom15070956 · Cited by 11
von Eckardstein, A., & Robert, J. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.321546 · Cited by 10
Beclin 1 regulates astrocyte phagocytosis and phagosomal recruitment of retromer
Silva, E. G. L., Delgadillo, Y., White, R., & Lucin, K. M. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102100 · Cited by 6
Potapenko, A., Frey, K., Schlumpf, E., Robert, J., Wollscheid, B., von Eckardstein, A., & Rohrer, L. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100665 · Cited by 6
The WASH-complex subunit Strumpellin regulates integrin αIIbβ3 trafficking in murine platelets
Schurr, Y., Reil, L., Spindler, M., Nieswandt, B., Machesky, L. M., & Bender, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-36387-8 · Cited by 3
LDL transcytosis passes through the trans-Golgi network and requires Rab10
Ho, T. W. W., Wang, C., & Lee, W. L. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100893 · Cited by 3
Jee, Y. H., Lui, J. C. K., Marafi, D., Xia, Z., Bhatia, R., Zhou, E., Herman, I., Temnycky, A. G., Whalen, P. E., Elliot, G., et al. (2024) · Genetics in Medicine Open · doi:10.1016/j.gimo.2024.101915 · Cited by 2
RNF130 Adds Further Complexity to the Regulation of LDL Receptor Activity
Robert, J., Panteloglou, G., & von Eckardstein, A. (2023) · Circulation Research · doi:10.1161/circresaha.123.322555 · Cited by 2
Shrestha, P., Katta, K., Talsma, D. T., Naggi, A., Hillebrands, J., van de Sluis, B., & van den Born, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.798088 · Cited by 1
Mechanism of the Regulation of Plasma Cholesterol Levels by PI(4,5)P2
Qin, Y., & Medina, M. W. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_3 · Cited by 1
Heida, A., van Dijk, T. H., Smit, M., Koehorst, M., Koster, M. H., Kloosterhuis, N., Havinga, R., Bloks, V. W., Wolters, J. C., de Bruin, A., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159445 · Cited by 1
Self-citationCOPI Coatomer Regulates Several Steps of HDL Metabolism
Panteloglou, G., Zanoni, P., Law, C. S., Woods, B., Othman, A., Yalçınkaya, M., Nørrelykke, S. F., Rzepiela, A. J., Stoma, S., Stebler, M., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324616 · Cited by 1
Self-citationYu, Q., Wang, X., Wang, S., Wang, H., Qin, C., Qin, J., Li, E., & Chen, L. (2026) · Animal nutrition · doi:10.1016/j.aninu.2025.09.019 · Cited by 1
Sharing lessons learnt across European cardiovascular research consortia
de Jong, L., Bobeldijk‐Pastorova, I., Erdmann, J., Bijker-Schreurs, M., Schunkert, H., Kuivenhoven, J. A., & van Gool, A. J. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.01.009 · Cited by 1
Self-citationApplying lipidomics strategies to study lipid metabolic diseases
Zhang, W. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.169407826 · Cited by 1
Schrader, M., (21832286), M. I., & (11103897), J. C. (2022) · Frontiers research topics · doi:10.3389/978-2-83250-838-1
van Zutphen, T., Struik, D., Liu, W., Liu, S., Sermikli, B. P., Wolters, J. C., Verkade, H. J., Atkins, A. R., Downes, M., Evans, R. M., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101660
Self-citationEndosomal trafficking complexes in the regulation of liver metabolism
Motzler, K. F., Herzig, S., & München, T. U. (2023)
Brunton, K., Ragsac, M. F., & Amariuta, T. (2026) · medRxiv · doi:10.64898/2026.02.23.26346922
L'interrelation entre les régulateurs de tri endosomal RAB21, Retromer et le complexe WASH
Maran, S. V. (2022) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Yalçınkaya, M., Hsu, C.-C., Li, L., Wang, R., Ngai, D., Vela, P. S., Fernández-Maestre, I., Olszewska, M., Liu, W., Chen, M., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.080527
Verzijl, C. R. C., Barbosa, M. G., Vos, D. Y., Heida, A., Caillaud, A., Vanharanta, L., Ge, X., Tissink, J. J., Koster, M. H., Smit, M., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102456
Self-citation
Metadata
- Authors
- Wijers, M., Zanoni, P., Liv, N., Vos, D. Y., Jäckstein, M. Y., Smit, M., Wilbrink, S., Wolters, J. C., van der Veen, Y. T., Huijkman, N., Dekker, D., Kloosterhuis, N., van Dijk, T. H., Billadeau, D. D., Kuipers, F., Klumperman, J., von Eckardstein, A., Kuivenhoven, J. A., & van de Sluis, B.
- Affiliations
- University Medical Center Groningen (NL)
- University of Zurich (CH)
- Utrecht University (NL)
- Mayo Clinic (US)
- Corresponding author
- van de Sluis, Bart
- ORCID
- Venue
- JCI Insight
- Published
- 2019-06-06
- Volume
- 4
- Issue
- 11
- ISSN
- 2379-3708 (ISSN-L)
- PMC
- PMC6629119
- OpenAlex
- W2948659925
- Semantic Scholar
- bdbc1c7ecc7364cb8530ac136cae96dc8900825f
- Cited by
- 44
- References
- 74
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 3 · 2019: 1
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- JCI Insight (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- NWO-ALW (817.02.022)
- EU FP7 (TransCard (FP7-603091-2))
- the Dutch heart foundation (CVON 2017-20)
- dutch heart foundation (2015T068)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- WASH complex, LDL cholesterol, HDL cholesterol, LDL receptor, LRP1, scavenger receptor class B type I, endosomal trafficking, PCSK9, endosomal recycling, hepatocytes, serum cholesterol
- MeSH terms
- Animals, Female, Cholesterol, HDL, Cholesterol, LDL, Liver, Male, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Vesicular Transport Proteins, Scavenger Receptors, Class B, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review